Nightly Progesterone Raises Allopregnanolone, Which May Harm Brain Health | Felice Gersh, MD
Why It Matters
Elevated nightly allopregnanolone could increase dementia risk, urging a reevaluation of hormone‑based sleep aids and prompting safer alternatives.
Key Takeaways
- •Nightly progesterone spikes allopregnanolone levels in the brain.
- •Excess allopregnanolone enhances GABA activity, causing sedation and fog.
- •High allopregnanolone linked to impaired memory formation in humans.
- •Chronic GABA‑agonist exposure significantly raises lifetime dementia risk.
- •Consider alternative sleep strategies to avoid nightly neurosteroid buildup.
Summary
The video examines how nightly progesterone supplementation elevates the neurosteroid allopregnanolone, a metabolite that strongly modulates the brain’s GABA‑A receptors. Dr. Felice Gersh explains that while GABA activation is essential for sleep, excessive allopregnanolone can produce pronounced sedation, brain‑fog, and notably reduced memory formation.
Allopregnanolone’s mechanism mirrors that of benzodiazepines such as Valium and Xanax, binding to a distinct site on the GABA‑A complex and amplifying inhibitory signaling. Limited human data already suggest a correlation between elevated allopregnanolone and poorer episodic memory, and epidemiological studies on chronic benzodiazepine use demonstrate a heightened lifetime risk of dementia when taken nightly.
Gersh cites research showing that constant exposure to GABA‑enhancing agents—whether pharmacologic or endogenous—can impair cognitive resilience. She warns that the “too much of a good thing” principle applies: sustained high levels of allopregnanolone may compromise neural plasticity and accelerate neurodegenerative processes.
The implication for clinicians and patients is clear: routine nighttime progesterone or any regimen that spikes allopregnanolone should be reassessed. Alternative sleep hygiene practices, non‑GABA‑targeting therapies, and careful monitoring of hormone dosing may mitigate potential long‑term brain health risks.
Comments
Want to join the conversation?
Loading comments...